Search
for
Sort by
Research 541–570 of 1000+
- Oral Contraceptives: Their Mode of Action and Dermatologic Applications
- Oral cyclosporin does not arrest progression of androgenetic alopecia.
- Oral pathology: Clinical pathologic correlations (ed 3)
- Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride
- Elevation of serum triglyceride and cholesterol levels from isotretinoin therapy with concomitant oral contraceptives
- Low‐Dose Oral Versus Topical Minoxidil in Androgenetic Alopecia: A Randomized, Double‐Blind, Double‐Dummy Controlled Trial
- Pharmacokinetics and Safety of 1 mg Oral Minoxidil Tablets in Healthy Female Volunteers: A Phase I Randomized Crossover Clinical Trial
- Development and In Vitro Characterization of Neusilin® US2-Based Solid Self-Nanoemulsifying Drug Delivery System for Oral Administration of Finasteride
- Bicalutamide: A potential new oral anti-androgenic drug for female pattern hair loss - A case series
- Clinical and Haematological Improvement Following a 90-Day Oral Iron Supplementation Regimen in Adults with Iron Deficiency Anemia - A Prospective Real-World Observational Study
- Gastrointestinal Side Effects of Low-Dose Oral Minoxidil in Patients with Alopecia: An Underrecognized Association
- Quantifying the systemic and oral symptoms of Long COVID: A comprehensive cross-sectional survey analysis.
- Efficacy and Safety of Oral Janus Kinase Inhibitors in Adults and Adolescents with Alopecia Areata: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
- The efficacy and safety of oral minoxidil greater than 5 mg daily in hair loss disorders
- The efficacy and safety of oral minoxidil greater than 5 mg daily in hair loss disorders
- Increased Efficacy of Daytime Low-dose Oral Minoxidil Dosing for Androgenetic Alopecia: A Retrospective Study
- The efficacy and safety of oral minoxidil greater than 5.1-10 mg daily in hair loss disorders
- The efficacy and safety of oral minoxidil greater than 5 mg daily in hair loss disorders
- The efficacy and safety of oral minoxidil greater than 5 mg daily in hair loss disorders: A systematic review
- The efficacy and safety of oral minoxidil greater than 5 mg daily in hair loss disorders: A systematic review
- 74924 Oral Minoxidil for Pediatric and Adolescent Hair Loss: A Cross-Sectional Survey of Satisfaction and Perceived Benefit
- 76626 Adjunctive Combined Regenerative Technique (CRT) vs Oral Minoxidil Alone for Androgenetic Alopecia: A Six-Month Retrospective Study
- Low Dose Oral Minoxidil in Androgenetic Alopecia
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- ORAL MINOXIDIL EFFICACY AND SAFETY IN MALE ANDROGENETIC ALOPECIA - A LITERATURE REVIEW
- Dose-Dependent Increases in Carotid Intima-Media Thickness Associated with Oral Minoxidil but Not Dutasteride in Healthy Young Males: A Randomized Controlled Pharmacological Trial
- Oral tofacitinib for recalcitrant lichen planus pigmentosus: A hospital-based retrospective study
- P166 Real-world efficacy and tolerability of oral dutasteride combined with oral minoxidil for male androgenetic alopecia: a retrospective cohort study
- Frontal Fibrosing Alopecia Successfully Treated with Intralesional Betamethasone and Oral Hydroxychloroquine: A Case Report
- No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study